drugset / Trial / NCT02860039

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

NCT02860039

RandomizedParallel-groupTriple-blindPrevention

Summary

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

Timeline

Start
2016-09
Primary completion
2021-12-01
Completion
2024-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular
Comparator Quadrivalent influenza vaccine Vaccine Intramuscular